At a glance

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

No development reported
Solid tumours

Most Recent Events

16 Jul 2016
No recent reports of development identified for phase-I development in Solid-tumours in USA (PO, Capsule)

08 Jun 2010
Adverse events, pharmacokinetics, pharmacodynamics and efficacy data from a phase I trial in late-stage Solid tumours presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO-2010)

11 May 2007
Data presented at the 98th Annual Meeting of the American Association for Cancer Research (AACR-2007) added to the Cancer pharmacodynamics and pharmacokinetics sections

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription